Format

Send to

Choose Destination
Clin Infect Dis. 2004 Aug 15;39(4):584-7. Epub 2004 Jul 30.

Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.

Author information

1
Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa 52242, USA.

Abstract

We report 4 cases of invasive zygomycosis in hematopoietic stem cell transplant recipients, all occurring after May 2003, when voriconazole began to be used as antifungal prophylaxis. No cases of zygomycosis had been detected in this population in the 3 years prior to May 2003. All 4 patients were receiving immunosuppressive therapy for presumed graft-versus-host disease. Profoundly immunosuppressed patients receiving voriconazole prophylaxis remain at risk for less-common pathogens that are intrinsically resistant to this agent.

Comment in

PMID:
15356827
DOI:
10.1086/422723
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center